PHAXIAM Therapeutics S.A. Comprehensive Income
PHAXIAM Therapeutics S.A. reported Comprehensive Income of -EUR 12.32 million for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2023-09-26
| Period end | Comprehensive Income 6 month | Comprehensive Income 12 month | Comprehensive Income 12 month as first filed |
|---|---|---|---|
| 2023-06-30 | -12.32M EUR 6-K · filed 2023-09-26 | ||
| 2022-12-31 | 194.00K EUR 20-F · filed 2023-03-28 | ||
| 2022-06-30 | -734.00K EUR 6-K · filed 2023-09-26 | ||
| 2021-12-31 | -54.26M EUR 20-F · filed 2023-03-28 | ||
| 2021-06-30 | -28.06M EUR 6-K · filed 2022-09-12 | ||
| 2020-12-31 | -72.92M EUR 20-F · filed 2023-03-28 | ||
| 2020-06-30 | -34.95M EUR 6-K · filed 2021-09-20 | ||
| 2019-12-31 | -61.46M EUR 20-F · filed 2022-04-27 | ||
| 2019-06-30 | -29.38M EUR 6-K · filed 2020-09-21 | ||
| 2018-12-31 | -38.27M EUR 20-F · filed 2021-03-08 | -38.27M EUR 20-F · filed 2019-03-29 | |
| 2018-06-30 | -18.99M EUR 6-K · filed 2019-09-26 | ||
| 2017-12-31 | -33.56M EUR 20-F · filed 2020-03-18 | ||
| 2016-12-31 | -21.91M EUR 20-F · filed 2019-03-29 | ||
| 2015-12-31 | -15.02M EUR 20-F/A · filed 2018-05-23 |